Earnings Call · Q2 FY2021·2021-07-31

Q2 21EPS +22.00%·Rev n/aQ1 21EPS -83.33%·Rev n/aQ4 20EPS -2.13%·Rev n/aQ3 20EPS +62.07%·Rev n/a⚠ consensus missing

Travere Therapeutics, Inc. TVTX

Chris Cline — Investor Relations

Dr. Eric Dube — Chief Executive Officer

Dr. Noah Rosenberg — Chief Medical Officer

Peter Heerma — Chief Commercial Officer

Laura Clague — Chief Financial Officer

−0.7%1d on move date−0.2% vs SPY3d+2.3%5d+5.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TVTX calls or request research access.

More TVTX calls Browse calls Request research access